Oct. 4th, 2011

the_future_modernes: a yellow train making a turn on a bridge (icecream cones)
[personal profile] the_future_modernes


Revolting Women: Geneviève Pastre



Pastre’s coming-out, at the age of 56, followed successful careers as an academic, theatre practitioner and poet.

...

It was during her time as a [theatre] director that Pastre began gaining recognition as a poet, subsequently publishing ten poetry collections between 1972 and 2005. In 1976, having privately begun to live with a woman, she began agitating for lesbian rights in France. Her official coming-out was a declaration in print: the 1980 essay on female sexuality, De L’Amour lesbien (About Lesbian Love).

By 2000, Pastre had published a further five books, including historical works. As the titles of Homosexuality in the Ancient World and Athens and the Sapphic Peril suggest, Pastre was one of the first feminist theorists to deconstruct classical myths. Challenging the dominance of Foucault’sHistory of Sexuality, she argued that Foucault – and with him the male academy – had misinterpreted both ancient languages and lesbian sexuality.

Pastre’s greatest contribution, however, has undoubtedly been to the transformation of queer rights, and thus queer life, in France. A year before coming out in the pages of De L’Amour lesbien, Pastre co-founded Comité d’Urgence Anti-Répression Homosexuelle(CUARH). Mobilising the smaller, disparate French gay rights groups that already existed – including David et Jonathan (gay Christians), and Beit Haverim (gay Jews) – CUARH organised a massive protest on 4th April 1981. 10,000 French LGBT people and allies joined what has since been recognised as France’s first ever gay rights march, campaigning for homosexual sex (decriminalised since the French revolution) to have the same age of consent as for heterosexuals.

 

Read more... )
the_future_modernes: a yellow train making a turn on a bridge (FAIL-set-on-fire)
[personal profile] the_future_modernes
Secret Cables: Big Pharma's Prints Cover US Foreign Policy


Among the hundreds of thousands of secret US State Department cables recently released by WikiLeaks, the controversial whistleblower website, a cache reveals US diplomats defending the interests of big pharmaceutical companies, even at the risk of the hosting nation’s own public health priorities. The memos dutifully detail the many embassy meetings with local Big Pharma reps, during which US officials are presented with laundry lists of issues to raise with one or another local government ministry. Invariably the goal of the exercise is for pharma to pressure the US to pressure the host country to give favorable treatment to expensive brand name drugs, typically by preventing in-country manufacturing or marketing of far cheaper generic versions.

Separate cables show such industry profiteering tactics threatening to taint US diplomatic relations in emerging nations such as Hong Kong, the Dominican Republic, the Philippines, Turkey, Venezuela, Saudi Arabia, and India. Overall, a familiar picture emerges of a diplomatic corps if not held hostage by, at least a captive audience to, the financial interests of the biggest American pharma companies as they come into covert conflict with developing nations that quite naturally prioritize the health care of their people over the high margins that Big Pharma has come to expect. With several hundred drugs and vaccines in development to treat addiction, the scourge of hundreds of millions worldwide, the affordability and accessibility of these innovative (and, no doubt, expensive) medicines will become a pitched battle in global public health over the next decade. The outcome of the skirmishes sketched in the WikiLeaks cables will help decide whether profits or people prove victorious.

The cables by no means paint a uniform portrait of government lackeys doing industry's bidding. Many memos betray a between-the-lines irritation at pharma's monomaniacal self-interest. Still, there is a disturbing silence on the obvious moral or ethical objections to industry demands for high price, long patents, and other protections despite the cost in human lives. Only a single cable—from the outgoing US ambassador to Poland in 2009—lays bare the vast greed that drives these complex, highly technical negotiations.

The developing nations, contrary to what you might expect, in many ways hold the best cards in this political game. Emerging nations have the fastest-growing economies, the most upwardly mobile middle classes, and the biggest untapped markets in the world. And in their impressive pushback against Big Pharma, India has been the 800-pound gorilla over the past decade. A democracy with well-educated but relatively inexpensive brain power, the pharma industry views India not merely as a market but as a potential new hub of drug development and testing.

Aware of its advantage, India has played hardball, starting with its approval of local generic HIV drugs for its hundreds of thousands of citizens with the virus—a defiant challenge to Big Pharma, which had refused to discount its own brand-name AIDS drugs to affordable levels. (In the US, HIV treatment costs as much as $15,000 a year; the Indian generic knocked out knockoffs with a $350 price tag.) In addition, India’s supreme court has been fearless in shooting down foreign pharmas when they sue for patent infringement by Indian generic companies. When an emerging nation's entire legal and legislative apparatus unite to oppose industry interests, the company can either fold its hand or fold up its tent. When drug companies retaliated by boycotting India and refusing to sell new drugs there, they attracted universal opprobrium for denying sick people medicines.


MORE
the_future_modernes: a yellow train making a turn on a bridge (Default)
[personal profile] the_future_modernes
NAMIBIA Skulls Repatriated - But No Official German Apology

BERLIN, Oct 4, 2011 (IPS) - A delegation of Namibian government representatives and leaders of the indigenous Herero and Nama people who came to Germany to repatriate 20 skulls of their ancestors were once again disappointed in their hopes for dialogue and an official apology.

The skulls were of victims of the mass murder of 80,000 Herero and Nama between 1904 and 1908, which were stolen by the former colonial 'Kaiserreich' for racial research some 100 years ago.

"When the Great Powers partitioned Africa in 1884, unfortunately we were allotted to the Germans," said Advocate Krukoro of the Ovaherero Genocide Committee, one of the 60 Namibian delegates, during the Sept. 27-Oct. 2 visit to Berlin.

In 1904, some 17,000 German colonial troops commanded by General Lothar von Trotha launched a brutal war of extermination against the Herero and Nama people, after they revolted against the continued deprivation of land and rights. Following their defeat at Waterberg on Aug. 11, 1904, they were hunted, murdered or driven deep into the Omaheke desert where they died of thirst.

Thousands of men, women and children were later interned in German concentration camps, and died of malnutrition and disease. The territories of the Herero and Nama people were seized, their community life and means of production destroyed. The discussion about the mass murder did not start until Namibia gained independence from South Africa in 1990.

Germany's foreign ministry has routinely avoided the use of the term "genocide" in dismissing the Herero and Nama peoples' claims for compensation, using instead vague phrases such as "Germany's historic responsibility with respect to Namibia."


Cornelia Pieper, the minister of state in the German foreign office, did the same this time around. "Germans acknowledge and accept the heavy moral and historical responsibility to Namibia," she said on Sep. 30 at the Charité University in Berlin, which hosted the ceremony in which the skulls of nine Herero and eleven Nama people were handed over to the Namibian delegation.

The remains of four females, 15 males and one child were part of the Charité anatomical collection. They were used by German scientists in research that had the aim of proving the supposed racial superiority of white Europeans over black Africans.

Now, 100 years later, the president of the executive board of the 300-year-old institution, Karl Max Einhaeupl, deplored "the crimes perpetrated in the name of a perverted concept of scientific progress" and said: "We sincerely apologise".

The treatment of the Herero and Nama people in Namibia – mass extermination on the grounds of racism, extermination through labour, expropriation of land and cattle, research to prove the alleged superiority of white people – is widely seen as a precursor to the Holocaust. MORE

Profile

Discussion of All Things Political

January 2013

S M T W T F S
  12345
6789101112
13141516171819
20212223242526
2728 293031  

Most Popular Tags

Style Credit

Expand Cut Tags

No cut tags